The increasingly popular class of GLP-1 receptor and GIP combined medications, like tirzepatide, semaglutide, and the recently introduced retatrutide, offer significant advances in diabetes management . https://ghk-cu-copper-peptide686344.beneficialblog.com/62143832/tirzepatide-a-comparative-review